Literature DB >> 16614991

Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis.

Ali Siddiqui1, Hanumantha Ancha, Dustin Tedesco, Stanley Lightfoot, Charles A Stewart, Richard F Harty.   

Abstract

The aims of this study were to examine the ability of the antioxidant N-acetylcysteine (NAC) and mesalamine (5-ASA) alone and in combination to affect TNBS-induced colitis in rat. Three days following induction of TNBS colitis rats were randomized to receive daily intracolonic treatment with NAC, 5-ASA, and NAC plus 5-ASA for 5 or 8 days. At the end of the treatment period macroscopic and microscopic colonic injuries were scored. Myeloperoxidase (MPO) activity and cytokine gene expression were measured in colonic tissues. Results indicated that treatment with NAC plus 5-ASA caused a significantly greater reduction in colonic injury than either agent alone. Furthermore, combination therapy inhibited significantly MPO activity and inflammatory cytokine gene expression in the distal colon of TNBS-treated animals. The beneficial effects of NAC plus 5-ASA on reduction of colonic injury and promotion of healing were most evident after 8 days of treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614991     DOI: 10.1007/s10620-006-3194-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  Current theories on the causes of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Gastroenterol Clin North Am       Date:  1999-06       Impact factor: 3.806

2.  Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.

Authors:  H Bantel; C Berg; M Vieth; M Stolte; W Kruis; K Schulze-Osthoff
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

3.  Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis.

Authors:  Y Yoshida; A Iwai; K Itoh; M Tanaka; S Kato; R Hokari; T Miyahara; H Koyama; S Miura; M Kobayashi
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

4.  Contribution of oxygen-derived free radicals to experimental necrotizing enterocolitis.

Authors:  D A Clark; D M Fornabaio; H McNeill; K M Mullane; S J Caravella; M J Miller
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

5.  Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice.

Authors:  D M McCafferty; M Miampamba; E Sihota; K A Sharkey; P Kubes
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

6.  Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase.

Authors:  B Zingarelli; C Szabó; A L Salzman
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 7.  Nitric oxide and intestinal inflammation.

Authors:  P Kubes; D M McCafferty
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

8.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

Authors:  D Rachmilewitz; F Karmeli; E Okon; M Bursztyn
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

Review 9.  Effects of antirheumatic agents on cytokines.

Authors:  P Barrera; A M Boerbooms; L B van de Putte; J W van der Meer
Journal:  Semin Arthritis Rheum       Date:  1996-02       Impact factor: 5.532

10.  Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis.

Authors:  J L Wallace
Journal:  Can J Physiol Pharmacol       Date:  1988-04       Impact factor: 2.273

View more
  12 in total

1.  5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream.

Authors:  Caroline Caltabiano; Felipe Rodrigues Máximo; Ana Paula Pimentel Spadari; Daniel Duarte da Conceição Miranda; Marcia Milena Pivatto Serra; Marcelo Lima Ribeiro; Carlos Augusto Real Martinez
Journal:  Dig Dis Sci       Date:  2010-11-02       Impact factor: 3.199

2.  Antioxidant Analogue 6-Amino-2,4,5-Trimethylpyridin-3-ol Ameliorates Experimental Colitis in Mice.

Authors:  Hoyul Lee; Joon Seop Lee; Hyun Jung Cho; Yu-Jeong Lee; Eun Soo Kim; Sung Kook Kim; Tae-Gyu Nam; Byeong-Seon Jeong; Jung-Ae Kim
Journal:  Dig Dis Sci       Date:  2020-05-02       Impact factor: 3.199

3.  Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities.

Authors:  Göksel Sener; Halil Aksoy; Ozer Sehirli; Meral Yüksel; Cenk Aral; Nursal Gedik; Sule Cetinel; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

4.  N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.

Authors:  Luis G Guijarro; Jose Mate; Javier P Gisbert; Jose Luis Perez-Calle; Ignacio Marin-Jimenez; Encarna Arriaza; Tomas Olleros; Mario Delgado; Maria S Castillejo; David Prieto-Merino; Venancio Gonzalez Lara; Amado-Salvador Pena
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

5.  Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats.

Authors:  Hanumantha R Ancha; Ravi R Kurella; Christine C McKimmey; Stanley Lightfoot; Richard F Harty
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 6.  Mitochondrial dysfunction in inflammatory bowel disease.

Authors:  Elizabeth A Novak; Kevin P Mollen
Journal:  Front Cell Dev Biol       Date:  2015-10-01

Review 7.  Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.

Authors:  Tian Tian; Ziling Wang; Jinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

8.  Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model.

Authors:  Sónia R Pereira; Rita Pereira; Isabel Figueiredo; Victor Freitas; Teresa C P Dinis; Leonor M Almeida
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

Review 9.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

10.  Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis.

Authors:  Ashish K Singh; Rosanne Y Hertzberger; Ulla G Knaus
Journal:  Redox Biol       Date:  2018-02-12       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.